Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.
Press releases published on May 5, 2025

Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference
BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …

Longan Craft Announces Strategic Expansion Alongside New Fabric and Sewing Products
Kowloon, Hong Kong , May 05, 2025 (GLOBE NEWSWIRE) -- Longan Craft, a trusted global fabric retailer based in Hong Kong, today announced an expanded strategic focus and new product offerings within the fast-changing fabric and sewing landscape. In response …

U.S. Smart Manufacturing Market to Hit $116.48 Billion by 2029 – Lead the Next Industrial Revolution!
Delray Beach, FL, May 05, 2025 (GLOBE NEWSWIRE) -- The report "Smart Manufacturing Market - Edge Computing, Industrial 3D Printing, Robots, Sensor, Machine Vision, Artificial intelligence, Cybersecurity, Digital Twin, Private 5G, AGV, AMR, AR …

Breath Analyzer Market Size Projected to Surge $3.68 Billion Growth by 2030, With CAGR of 15.19% | The Insight Partners
US …

Veterinary Vaccines Market Size to Surpass USD 13.67 Billion by 2031 with 6.0% CAGR | The Insight Partners
US …

Gene Therapy Market to Hit US$36.55 Billion by 2032 with 19.4% CAGR | MarketsandMarkets™
Delray Beach, FL, May 05, 2025 (GLOBE NEWSWIRE) -- The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching US$8.85 billion in 2024 and an impressive US$36.55 billion by 2032. Market …

Rakovina Therapeutics Announces Appointment of Dr. David Kideckel as Chief Financial Officer
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …

Latin Metals Announces Private Placement for Gross Proceeds up to $1.0 Million
Not for distribution to United States newswire services or for release, publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- …

Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025
LAKE FOREST, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release first quarter 2025 financial results on Monday, May 12, 2025, after the market close. Additionally …

Early Warning News Release Regarding the Securities of Euromax Resources Ltd.
NICOSIA, Cyprus, May 05, 2025 (GLOBE NEWSWIRE) -- VVV Commodities and Resources Ltd (the "Acquiror"), acquired 113,987,645 common shares (the “Common Shares”, and each, a “Common Share”) in the capital of Euromax Resources Ltd. (the "Issuer") at a deemed …

2025年5月、東京で開催 – アジア最大級のバイオマス・バイオカーボン・トリファイドバイオマスサミットに300名以上が参集予定
TOKYO, JAPAN, May 5, 2025 /EINPresswire.com/ -- アジアのバイオマス・バイオエネルギー市場が急速に進化する中、CMT(Centre for Management Technology)は、第15回 Biomass Pellet Trade Asia …

THE INTERNATIONAL SPACE DEVELOPMENT CONFERENCE TO HOST ASTRONAUTS AS NEXTGEN SPEAKERS
The National Space Society’s Annual Conference Will be Held on June 19-22 in Orlando KENNEDY SPACE CENTER, CA, UNITED STATES, May 4, 2025 /EINPresswire.com/ -- The National Space Society’s 43rd annual International Space Development Conference® (ISDC®) …

Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025
CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …

Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress
Urges Stockholders to Vote FOR Reverse Stock Split Proposal at Upcoming Annual Meeting as Recommended by Leading Independent Proxy Advisory Firms SOUTH SAN FRANCISCO, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today issued the …

Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia
Operational Realignment Expected to Deliver Over $6 Million in Annual Cost Savings Company Exploring CDMO Expansion Opportunities in Southeast Asia San Antonio, TX , May 05, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (OTC: SCPX) (“Scorpius” or “the …

Praxis Precision Medicines Highlights DEE Clinical Program Updates at Virtual Investor Event
BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …

Immutep’s Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1
Complementary nature of these two immunotherapies leads to excellent 17.6-month median Overall Survival in head and neck cancer patients with PD-L1 CPS <1 Mature overall survival data builds on encouraging high response rates with multiple complete …

HomesToLife Ltd Announces Acquisition of HTL Marketing Pte Ltd, with 2024 Sales of US$330 Million
Singapore, May 05, 2025 (GLOBE NEWSWIRE) -- HomesToLife Ltd (NASDAQ: HTLM) (“HomesToLife” or the “Company”), the holding company of one of the leading home furniture products retail chains in Singapore, today announced that it has entered into a definitive …

Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
– Fast Track Designation highlights potential of ATH434 to address high unmet need for individuals with MSA – MELBOURNE, Australia and SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the …

Hazer and KBR Enter Global Deal to Accelerate Licensing and Commercialisation
Highlights Binding strategic alliance with KBR (NYSE: KBR), a world-leading engineering group and global technology licensor set to supercharge Hazer’s commercialisation strategy Hazer is KBR’s exclusive partner for marketing and licensing of methane …